Own Experience of Treatment of Patients with Post-COVID Rhinosinusitis: Efficiency and Reliability
Before the outbreak ofthe pandemic, the growth of antibiotic resistance was already noted in most countries, which was associated with the frequent appointment of systemic antibacterial agents for viral infections, active self-medication ofthe population. The availability of ENT organs for local exposure is not always fully used by specialists. The use of topical antibiotics solves several tasks at once - effective treatment and reduction ofthe threat of antibiotic resistance. The fear of a new infection, disagreements in the tactics of managing patients in the first months ofthepandemic, led to the active use of systemic antibiotics. In thefuture, the unjustifiability of this tactic was proved, but it had almost no effect on the frequent administration of systemic drugs, and sometimes several at once to one patient with a viral lesion, without the development of bacterial complications. The use of topical antibacterial drugs allows you to quickly reach high concentrations in the focus of infection and avoids side effects ofsystemic. Polydexa nasal spray in the treatment of post-corneal prolonged rhinosinusitis makes it possible to significantly improve the well-being of patients by the 3rd day of treatment and reduce inflammatory changes in the nasal cavity.